IP Library › Assignment 044341/0207
Patent Assignment
Reel/Frame 044341/0207

Assignment of Assignor's Interest

Recorded: 2017-12-08 Pages: 4
Assignors
TSCHOPP, JURG
Executed: 2003-05-02
SCHNEIDER, PASCAL
Executed: 2003-05-02
Assignee
APOXIS, SA
22, CHEMIN DES CROISETTES 1066, EPALINGES, SWITZERLAND
Covered Properties (3)
Methods of Screening for a Compound That Inhibits the Interaction Between Baff and Bcma
Patent: 8,828,669 →
Application: 13/401,610 →
Publication: US 2012/0214687
Methods of Treating Autoimmune Diseases Using a B-Cell Maturation Antigen (Bcma)
Patent: 9,650,430 →
Application: 14/452,870 →
Publication: US 2015/0139992
Methods of Modulating Immune Responses Using Bcma Polypeptide
Application: 15/595,733 →
Publication: US 2018/0273605
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Change of Name Dec 8, 2017
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 044796/0054 →
Merger and Change of Name Dec 8, 2017
From: APOXIS SA; TOPOTARGET SWITZERLAND SA
To: TOPOTARGET SWITZERLAND SA
Reel/Frame 044796/0260 →
Assignment of Assignor's Interest Dec 8, 2017
From: THOMPSON, JEFFREY; AMBROSE, CHRISTINE; BROWNING, JEFFREY; MACKAY, FABIENNE
To: BIOGEN, INC.
Reel/Frame 044797/0673 →
Change of Name Dec 8, 2017
From: BIOGEN, INC.
To: BIOGEN IDEC MA INC.
Reel/Frame 044803/0870 →